Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population

Michael Bogart,1 Richard H Stanford,1 François Laliberté,2 Guillaume Germain,2 Jennifer W Wu,2 Mei Sheng Duh3 1GlaxoSmithKline plc, Research Triangle Park, NC, USA; 2Groupe d’Analyse, Ltée, Montréal, QC, Canada; 3Analysis Group Inc., Boston, MA,...

Full description

Bibliographic Details
Main Authors: Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:International Journal of COPD
Subjects:
Chronic obstructive pulmonary disease (COPD)
medication adherence
inhaled corticosteroids (ICS)
long-acting β2-agonists (LABA)
long-acting muscarinic-antagonists (LAMA)
multiple inhaler triple therapy
Online Access:https://www.dovepress.com/medication-adherence-and-persistence-in-chronic-obstructive-pulmonary--peer-reviewed-article-COPD

Internet

https://www.dovepress.com/medication-adherence-and-persistence-in-chronic-obstructive-pulmonary--peer-reviewed-article-COPD

Similar Items